Phase I and initial Phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck

David L. Schwartz, R. Bruce Montgomery, Bevan Yueh, Michael Donahue, Yoshimi Anzai, Raylene Canby, Raelene Buelna, Leslie Anderson, Charles Boyd, Janice Hutson, Kathryn Keegan

Radiation Oncology
Radiation Oncology - Administration

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I and initial Phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Phase I and initial Phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck

Fingerprint

Medicine & Life Sciences